Marika Deppmeyer's Contact Details

Marika Deppmeyer's Company Details

Phenogen Sciences, Inc.

Charlotte, NC, US • 20 - 49 Employees
BioTech/Drugs

Phenogen Sciences, Inc., a US division of Australia-based Genetic Technologies Limited, was established in 2010 as a global expansion strategy of the company's oncology and cancer management diagnostics business. As a pioneer in personalized healthcare, Phenogen Sciences offers novel predictive testing and risk assessment tools that help physicians proactively manage the health of their patients. Phenogen's lead product, BREVAGenplus™ is the first clinically validated predictive risk test that combines genetic and clinical data to categorize a woman's personal risk of developing breast cancer.Its parent company, Genetic Technologies Limited (NASDAQ: GENE) is based in Melbourne, Australia. For more than 20 years, the company has provided laboratory services in molecular diagnostics and was an early pioneer in recognizing important new applications for ‘non-coding' DNA (Deoxyribonucleic Acid). The company has since been granted patents in 24 countries around the world.